| 产品详情 |
| Edit |   |
|---|
| Product Name | PAI1, Recombinant, Human, Western Blot Control |
|---|
| Description | Purified (SDS-PAGE). PAI-1 is a serine protease inhibitor, which can exist, either in an active inhibitory conformation or in an inactive or latent conformation. PAI-1 is produced mainly by the endothelium but is also secreted by other tissue types including adipose tissue. PAI-1 is the principal inhibitor of tissue plasminogen activator and urokinase, therefore inhibiting fibrinolysis. Increased levels of PAI-1 have been linked with various conditions including cardiovascular disease, thrombosis, insulin resistance and obesity. Source: Recombinant corresponding to aa24-402 from mature human PAI-1, fused to 6x His-tag at N-terminal, expressed in E. coli. Applications: Suitable for use in Western Blot as a control. |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | WB |
|---|
| Other Names | PAI1, Recombinant, Human, Western Blot Control (Plasminogen Activator Inhibitor 1, PAI, PAI-1, Endothelial Plasminogen Activator Inhibitor, Serpin E1, SERPINE1, PLANH1) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | P4256-29A7 |
|---|
| Price | |
|---|
| Order / More Info | PAI1, Recombinant, Human, Western Blot Control from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|